Showing results (371-380 of 655) with videos related to
Sort By:
Pageof 66
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Clinical update on alefacept: consideration for use in patients with psoriasisJay N GadeJournal of Managed Care Pharmacy : JMCP|January 27, 2004
Clinical and economic impact of glatiramer acetate versus beta interferon therapy among patients with multiple sclerosis in a managed care populationDaniel A Ollendorf, Evguenia Jilinskaia, Merrikay Oleen-BurkeyJournal of Managed Care Pharmacy : JMCP|January 15, 2004
Markov modeling analysis of health and economic outcomes of therapy with valsartan versus amlodipine in patients with type 2 diabetes and microalbuminuriaDean G Smith, Anh B Nguyen, Corey N Peak, et al.Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Pharmacoeconomic challenges in the management of diabetic nephropathyRoger A RodbyJournal of Managed Care Pharmacy : JMCP|September 17, 2004
Current status of prospective drug utilization reviewThomas R Fulda, Alan Lyles, Mark C Pugh, et al.Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health planBrittany N Harris, Donna S West, Jill Johnson, et al.Journal of Managed Care Pharmacy : JMCP|April 5, 2005
Improving depression treatment by integrated careKathryn M RostJournal of Managed Care Pharmacy : JMCP|April 5, 2005
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settingsJosephine A Mauskopf, Clark Paramore, Won Chan Lee, et al.Journal of Managed Care Pharmacy : JMCP|April 5, 2005
Regression methods in the empiric analysis of health care dataGrant H SkrepnekJournal of Managed Care Pharmacy : JMCP|March 16, 2005
Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxisLida R Etemad, Winnie Yang, Denise Globe, et al.Pageof 66